Last reviewed · How we verify
NCT03184896: HiFit
Services Mapping Among Older Adults With Hip Fracture
trial testing Hip Fracture Surgery in Hip Fractures in 2,500 participants. Status unknown.
13 November 2021
Quick facts
| Lead sponsor | The George Institute for Global Health, China |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,500 |
| Start date | 14 November 2018 |
| Primary completion | 13 November 2021 |
| Estimated completion | 13 November 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Hip Fracture Surgery
Conditions studied
- Hip Fractures — all drugs for Hip Fractures →
Sponsor
The George Institute for Global Health, China
Who can join
65 and older, any sex, with Hip Fractures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hip fracture is a osteoporosis-related fracture with higher mortality, and is a major public health issue in China. The British Orthopedic Association and the British Geriatric Society have published the UK Blue Book, which summarizes current evidence and best practice in the hip fracture care and secondary prevention, but this kind of standardized practice in hip fracture care is not yet existed in China. The Blue Book standards will be used as the most contemporary evidence-based guidelines for management of hip fracture.This study is to prospectively examine the barriers and facilitators in the current management of hospital in China by comparing the Blue Book standards.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
The effectiveness of a co-management care model on older hip fracture patients in China - A multicentre non-randomised controlled study.
Zhang J, Yang M, Zhang X, He J, et al · · 2022 · cited 41× · PMID 35141666 · DOI 10.1016/j.lanwpc.2021.100348 -
Effect of the orthogeriatric co-management on older hip fracture patients with multimorbidity: a post-hoc exploratory subgroup analysis of a non-randomised controlled trial.
Liu T, Zhang X, Zhang J, Ye P, et al · · 2024 · cited 25× · PMID 39574198 · DOI 10.1186/s13018-024-05263-0 -
Orthogeriatric co-managements lower early mortality in long-lived elderly hip fracture: a post-hoc analysis of a prospective study.
Gao F, Liu G, Ge Y, Tan Z, et al · · 2023 · cited 12× · PMID 37723423 · DOI 10.1186/s12877-023-04289-z -
Prognostic nutritional index (PNI) is an independent predictor for functional outcome after hip fracture in the elderly: a prospective cohort study.
Chen Y, Bei M, Liu G, Zhang J, et al · · 2024 · cited 9× · PMID 39499371 · DOI 10.1007/s11657-024-01469-1 -
Association between admission inflammatory indicators and 3-year mortality risk in geriatric patients after hip fracture surgery: a retrospective cohort study.
Chen Y, Tu C, Liu G, Peng W, et al · · 2024 · cited 8× · PMID 39229251 · DOI 10.3389/fsurg.2024.1440990 -
Prognostic Nutritional Index (PNI) as an Independent Predictor of 3-Year Postoperative Mortality in Elderly Patients with Hip Fracture: A Post hoc Analysis of a Prospective Cohort Study.
Chen Y, Liu G, Zhang J, Ge Y, et al · · 2024 · cited 8× · PMID 39142664 · DOI 10.1111/os.14200 -
Association Between Hip Bone Mineral Density and Mortality Risk After Hip Fracture: A Prospective Cohort Study.
Ge Y, Chen Y, Liu G, Zhu S, et al · · 2023 · cited 7× · PMID 37347299 · DOI 10.1007/s00223-023-01109-9 -
Immediate weight bearing as tolerated versus delayed weight bearing following intramedullary fixation for geriatric intertrochanteric fractures: a post hoc analysis.
Li N, Cheng KY, Zhang J, Liu G, et al · · 2024 · cited 3× · PMID 39702062 · DOI 10.1186/s12891-024-08172-9
Verify or expand the search:
- PubMed search for NCT03184896
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hip Fracture Surgery
Trials testing the same drug.
- NCT05133648 — Anesthesia Technique in COVID-19 Positive Hip Fracture Patients · unknown
Other recruiting trials for Hip Fractures
Currently open trials in the same condition.
- NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
- NCT07002723 — Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality · NA · recruiting
- NCT06893406 — Cervical Myelopathy in Hip Fracture Patients · NA · recruiting
- NCT06565910 — Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG) · Phase 4 · recruiting
- NCT06455813 — What Laxative Should be Used After Hip Fracture Surgery? · Phase 4 · recruiting
Other The George Institute for Global Health, China trials
Trials by the same sponsor.
- NCT05326932 — Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial · NA · recruiting
- NCT04522102 — Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase · Phase 3 · completed
- NCT04140110 — Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2) · NA · terminated
- NCT03790800 — Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial · Phase 3 · completed
- NCT04037943 — NUTS for the Prevention of Cardiovascular Disease in Chinese Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03184896 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The George Institute for Global Health, China
- Last refreshed: 5 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03184896.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing